The development of chelators forming stable and inert complexes with Hg2+ is essential for harnessing the Auger electron-emitting radionuclide [197m/gHg]Hg2+ for cancer theranostics. Herein, thioether-containing polyazamacrocycles with distinct ring topologies (NO3S, TACD3S, DO4S, and TE4S) were evaluated to determine how backbone architecture and donor set govern Hg2+ binding. All ligands bound natHg2+ rapidly at ambient temperature, suggesting that ring topology has no influence on the complexation kinetics. In contrast, the thermodynamic behavior depends on the ligand structure: replacement of ethylenic with propylenic linkers decreases the complex stability, whereas reducing the number of donor atoms from eight to six has a moderate effect within fully ethylenic frameworks. NMR spectroscopy, DFT calculations, and crystallographic data reveal topology-dependent Hg2+ coordination trends. NO3S and TACD3S form six-coordinate N3S3 environments. In contrast, DFT-optimized structures for DO4S and TE4S correspond to a N4S2 coordination mode, while solution NMR shows a single averaged SCH3 resonance, indicating equivalent thioether environments on the NMR time scale. Radiolabeling with [197m/gHg]Hg2+ demonstrated a topology-dependent trend: NO3S enabled quantitative incorporation at 50 °C and outperformed DO4S, whereas TACD3S and TE4S failed to achieve full complexation. In human serum, [197m/gHg][Hg(NO3S)]2+ is exceptionally inert over 24 h, identifying NO3S as a promising scaffold for bifunctionalization and future in vivo application of this theranostic pair.
No takes yet. Share an insight, caveat, or question.
Tosato et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: